Skip to content

A Prospective, Single-institution Investigation of Opioid use and Survival of patients with advanced or recurrent non-small cell lung cancer.

A Prospective, Single-institution Investigation of Opioid use and Survival of patients with advanced or recurrent non-small cell lung cancer. - A Prospective, Single-institution Investigation of Opioid use and Survival of patients with advanced or recurrent non-small cell lung cancer.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000010363
Enrollment
Unknown
Registered
2013-04-01
Start date
2013-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

advanced or recurrent non-small cell lung cancer

Interventions

None listed

Sponsors

Gifu municipal hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: non-small cell lung cancer

Exclusion criteria

Exclusion criteria: nothing in particular

Design outcomes

Primary

MeasureTime frame
how opioid influenced survival after diagnosis

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026